Osteoporosis Trial, Recruiting NCT06265246 Sponsor: University of Saskatchewan Condition: Osteoporosis
Back to Osteoporosis

Osteoporosis Trial, Recruiting

NCT06265246
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 19 and 30 years old
  • You get less than 1,000 mg of calcium per day from your diet
  • You live in or around Saskatoon, Saskatchewan, Canada

Who may not be able to join:

  • You get more than 800 mg of calcium per day in total from food and supplements combined
  • You eat more than one serving of dairy products per day
  • Your body mass index (a measure of body weight relative to height) is above 30 (confirm with trial site)
  • You have a history of diseases affecting your bones, liver, hormonal glands, connective tissues, or lungs, or you have a thyroid condition or have had cancer
  • You have been diagnosed with a specific type of bone loss (osteoporosis) caused by a condition called hypoparathyroidism, where the body does not produce enough of a certain hormone
  • You have any hormonal disorders or imbalances
  • You currently take medications known to affect bone strength or density, such as steroids, water pills (diuretics), heparin, or cancer treatments
  • You have an allergy to cow's milk
  • You are pregnant, breastfeeding, or planning to become pregnant during the course of the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Hassan Vatanparast, MD, PhD, University of Saskatchewan

Phone: 306-966-8866

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Saskatchewan
Registry
ClinicalTrials.gov
Start date
1 September 2024
Est. completion
1 May 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Femoral neck bone mineral density

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov